The Latest Cardiac and Vascular News
SUWANEE, GA, April 02, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, received United States Patent US 10,238,405 on March 26, 2019 entitled “Blood Vessel Treatment […]
ANN ARBOR, Mich., April 01, 2019 (GLOBE NEWSWIRE) — Esperion (NASDAQ:ESPR) announced today that results from the 345 patient, 24-week, Phase 3, double-blind, placebo-controlled study of bempedoic acid (CLEAR Serenity, also known as Study 3) were published today in the Journal of the American Heart Association (JAHA). Bempedoic acid is being […]
ASHBURN, Va., April 2, 2019 /PRNewswire/ — American College of Clinical Pharmacology® & Cardiac Safety Research Consortium are pleased to announce the publication of their first co-authored paper, “The Potential Role of the J-Tpeak Interval in Pro-arrhythmic Cardiac Safety − Current State-of-the-Science from the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium,” in The […]
MINNEAPOLIS & AACHEN, Germany–(BUSINESS WIRE)–Hemovent GmbH announced today that its next-generation ECMO (ExtraCorporeal Membrane Oxygenation) system, MOBYBOX, has been validated in a pilot in vivo study by Minnesota Resuscitation Consortium, which is designing a ‘super ambulance’ that will be equipped with the latest technology to advance treatment of cardiac-arrest emergency patients. A ‘super […]
LAVAL, Québec, April 01, 2019 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia (HTG), today announced the publication of […]
CALGARY, Alberta, April 01, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that Dr. Alan J. Jacobs, M.S.EE, M.D, Ph.D. has been appointed the Company’s President and Chief Medical Officer. Dr. Jacobs previously acted as a medical consultant to […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has entered into a definitive agreement to raise approximately $52 million gross cash proceeds through the issuance of approximately 7.9 million new shares of the Company’s common stock […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced an agreement to settle approximately 75 percent of the previously disclosed litigation in the U.S. related to the Company’s 3T Heater-Cooler device. Under the terms of the agreement and subject to certain conditions, including acceptance of the settlement by […]
LOS ANGELES, CA , March 29, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), today announced an agreement with a nationally recognized hospital group to enhance the quality of the healthcare/patient experience through the use of its electroceutical therapeutic device, SofPulse®. Endonovo has been approved to […]
BEDMINSTER, N.J., and DUBLIN, Ireland, March 28, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that, as planned, it submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking an expanded indication for its […]
